Intra-Cellular Therapies Inc. revenue breakdown overview

Intra-Cellular Therapies Inc. revenue for the last year amounted to 464.37 M USD, the most of which — 464.37 M USD — came from its highest performing source at the moment, Small Molecule Drugs, the year earlier bringing 250.31 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Intra-Cellular Therapies Inc. 464.37 M USD, and the year before that — 250.31 M USD.